Learn more in our training program.
Join our membership network.
Attend our events and collaborate.
Add your voice to our policy matters.
Get involved in our genetic registry.
Donate to our cause.
The Latino Cancer Institute (TLCI) is a nationwide community and research network dedicated to solving the issues and burden of Latino cancer.
Cancer remains one of the leading causes of death among Hispanics/Latinos in the U.S., accounting for approximately 17% of deaths. At the same time, federal support for health equity and cancer disparities research is facing unprecedented cuts—making community-driven leadership more critical than ever.
Cancer affects Latino men and women differently, requiring targeted approaches. Among Latinas, breast cancer remains the most commonly diagnosed cancer and the leading cause of cancer death, while cervical cancer continues to pose a serious and largely preventable threat.
For Latino men, the challenges are equally urgent. Lung cancer remains the leading cause of cancer death, and Latino men are more likely to be diagnosed with prostate, colorectal, liver, and testicular cancers—often at later stages.
Our mission. The Latino Cancer Institute works to reduce the burden of cancer in Latino communities by convening expertise, amplifying community-informed research, and advocating for equitable cancer care. As public funding becomes more uncertain, philanthropic support helps ensure Latino communities are not left out of cancer research, policy discussions, or solutions. Learn more about our work.
For over 20 years, Founder Ysabel Duron has played a vital role in bringing together those dedicated to making a difference in the Latino cancer landscape. From cancer community workers and caregivers to international medical researchers and policymakers, Ysabel has forged important alliances in a field crowded with many competing interests and agendas.
It takes a savvy insider who has traveled this terrain far and wide to help the Latino cancer community at-large continue changing the landscape. TLCI offers the definitive road map.
The Latino Cancer Institute acts as a network for agencies, linking members to share knowledge and best practices. Connecting colleagues, peers and institutions is critical to The Institute’s ongoing mission to amplify and disseminate outstanding work in the cancer arena, and to support one another.
The Latino Cancer Institute provides opportunities to network, learn and collaborate with stakeholders in the cancer landscape including Latino cancer researchers.
The Latino Cancer Institute convenes leading experts, advocates, and community voices to examine critical cancer issues affecting Latino communities and to surface actionable insights. Recordings from TLCI’s recent Forums are now available—free to watch—covering cancer risks, disparities, and lived experiences across Latino women, men, children, and families. Watch Forum videos.
The Latino Cancer Institute leverages our united voice at the national table to advance Latino cancer concerns including education, services, funding, and research. Our aim is to be heard, understood and included in any proposed policy.
As a nonprofit organization, we rely on philanthropy and grants in our mission to support other agencies. Your funding allows us to continue the development of new programs and tools we can share with those making a difference in the lives of Latino cancer patients, survivors, and their caregivers.
Older adults who received the Shingrix shingles vaccine were 24% less likely to be diagnosed with dementia over four years in a study of more than 500,000 people. Researchers estimate the difference could amount to roughly one dementia case prevented for every 17 people vaccinated.
Researchers have found a way to supercharge natural killer cells, powerful immune cells that can attack cancer, so they can penetrate solid tumors and keep fighting once inside. In mice, these specially prepared tissue-resident cells slowed the growth of several tumors, including melanoma and head and neck cancers, and worked even better when paired with the antibody drug cetuximab.
People who reach 110 and beyond appear to have unusually large numbers of rare immune cells capable of killing abnormal cells. These CD4 cytotoxic T cells became more common with age and often expanded into large groups of nearly identical cells, suggesting the immune system was repeatedly responding to persistent threats.
Older adults with mild cognitive impairment and sleep problems who took at least 5,000 IU of vitamin D daily scored more than 13% higher on a cognitive test than those taking none. The preliminary findings suggest vitamin D could be worth studying as a potentially modifiable factor during an early window of cognitive decline.
A simple yeast-based food supplement may help restore the immune system’s ability to fight cancer, according to new research in mice. Scientists found that yeast beta-glucan reprogrammed early immune cells in the bone marrow, leading to stronger, longer-lasting cancer-fighting responses against colorectal, skin, and breast cancer cells.
AI may be able to predict how strongly someone will respond to a vaccine before they receive it. By analyzing antibody patterns in more than 4,000 people, researchers found signs of “immune readiness” that helped distinguish strong responders from weak ones. Surprisingly, even some healthy people responded poorly, while some immunosuppressed people mounted strong responses.
Sept. 18, 25 
